JPMorgan Chase & Co. Boosts Stake in Mettler-Toledo International Inc. (NYSE:MTD)

JPMorgan Chase & Co. raised its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 14.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 221,799 shares of the medical instruments supplier's stock after buying an additional 28,478 shares during the quarter. JPMorgan Chase & Co. owned about 1.05% of Mettler-Toledo International worth $332,634,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Blue Trust Inc. lifted its holdings in shares of Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier's stock worth $34,000 after purchasing an additional 17 shares during the period. Ashton Thomas Securities LLC purchased a new position in Mettler-Toledo International during the 3rd quarter worth approximately $37,000. Rothschild Investment LLC acquired a new stake in Mettler-Toledo International during the 2nd quarter valued at approximately $42,000. Itau Unibanco Holding S.A. purchased a new stake in shares of Mettler-Toledo International in the 2nd quarter valued at $42,000. Finally, Raleigh Capital Management Inc. boosted its holdings in Mettler-Toledo International by 272.7% in the third quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier's stock valued at $61,000 after purchasing an additional 30 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Analyst Ratings Changes

MTD has been the subject of several analyst reports. Wells Fargo & Company decreased their price objective on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an "equal weight" rating for the company in a report on Monday, November 11th. Citigroup upgraded Mettler-Toledo International from a "sell" rating to a "neutral" rating and lifted their price target for the company from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Stifel Nicolaus lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a research report on Monday, November 11th. Wolfe Research began coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They set a "peer perform" rating for the company. Finally, Evercore ISI increased their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an "in-line" rating in a report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $1,351.25.

Mettler-Toledo International Price Performance

NYSE MTD traded down $14.31 on Monday, hitting $1,219.92. The company had a trading volume of 73,545 shares, compared to its average volume of 134,426. The company has a market capitalization of $25.74 billion, a PE ratio of 32.89, a PEG ratio of 4.21 and a beta of 1.13. The company's fifty day moving average price is $1,264.02 and its 200-day moving average price is $1,361.19. Mettler-Toledo International Inc. has a 12-month low of $1,115.64 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million for the quarter, compared to analysts' expectations of $941.93 million. On average, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the company's stock in a transaction on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares in the company, valued at $314,820. This represents a 24.05 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now owns 6 shares in the company, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.